SCHEMBL22011182

SCHEMBL22011182

CCCc1cc(O)cc(F)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.46
PTPN11 Q06124 3/20 0.46
TAAR1 Q96RJ0 1/20 0.42
HMGCR P04035 1/20 0.41
TYR P14679 2/20 0.37
HSD17B3 P37058 1/20 0.37
PTGS2 P35354 6/20 0.36
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
CYP3A4 P08684 2/20 0.36
PTPN2 P17706 1/20 0.36
ALOX5 P09917 5/20 0.36
MAPT P10636 2/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24861846 0.83 ESR1 (0.44) PTPN1PTPN11TAAR1HSD17B3ESR1
SCHEMBL10061120 0.78 RIPK1 (0.42) HMGCRALOX5MAPTLMNAXBP1
SCHEMBL29314259 0.77 NOS1 (0.39) TAAR1HMGCRMAPTTSHRHTT
SCHEMBL22011782 0.77 HMGCR (0.34) HMGCR
SCHEMBL21082195 0.76 TAAR1 (0.64) PTPN1PTPN11TAAR1HMGCRTYR
SCHEMBL172038 0.76 HMGCR (0.36) HMGCRMAPTLMNAXBP1HIF1A
SCHEMBL22212108 0.75 TYR (0.50) PTPN1PTPN11HMGCRTYRHSD17B3
SCHEMBL27814767 0.75 TYR (0.55) HMGCRTYRHSD17B3ESR1ESR2
SCHEMBL28722613 0.75 PTPN1 (0.53) PTPN1PTPN11HMGCRTYRHSD17B3
SCHEMBL1760574 0.75 PTPN1 (0.53) PTPN1PTPN11HMGCRTYRPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 PTPN1 1969/4885PTPN11 2842/4885TAAR1 987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.